Amyloid precursor protein-mediated free radicals and oxidative damage: Implications for the development and progression of Alzheimer's disease

Journal of Neurochemistry

Volumn 96, Issue 1, 2006, Pages 1-13

  Reddy, P Hemachandra ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

In vitro studies; Mitochondria; Mitochondrial gene expression; Oxidative damage; Reactive oxygen species; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; ANTIOXIDANT; DONEPEZIL; FREE RADICAL; GALANTAMINE; GINKGO BILOBA EXTRACT; HUPERZINE A; MEMANTINE; REACTIVE OXYGEN METABOLITE; RIVASTIGMINE; TACRINE;

AGING; ALZHEIMER DISEASE; ANIMAL MODEL; COGNITION; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; GENE EXPRESSION; HUMAN; INFLAMMATION; MITOCHONDRION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE; ANIMAL; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PHYSIOLOGY;

ANIMALIA; GINKGO BILOBA; MUS MUSCULUS;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIOXIDANTS; CLINICAL TRIALS; DISEASE PROGRESSION; FREE RADICALS; GENE EXPRESSION REGULATION; HUMANS; MITOCHONDRIA; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 33644845279     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2005.03530.x     Document Type: Review

References (114)

1. Ahlemeyer B. Krieglstein J. 2003 Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease Pharmacopsychiatry 36 Suppl. 1 S8 S14
2. Akhondzadeh S. Noroozian M. Mohammadi M. Ohadinia S. Jamshidi AH. Khani M. 2003a Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomised, placebo controlled trial JNeurolNeurosurgPsychiatry 74 863 866
3. Akhondzadeh S. Noroozian M. Mohammadi M. Ohadinia S. Jamshidi AH. Khani M. 2003b Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer's disease: a double blind, randomized and placebo-controlled trial JClinPharmTher 28 53 59
4. Anandatheerthavarada AK. Biswas G. Robin MA. Avadhani NG. 2003 Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs mitochondrial function in neuronal cells JCellBiol 161 41 54
5. Babior BM. 2000 The NADPH oxidase of endothelial cells IUBMB Life 50 267 269
6. Babior BM. Lambeth JD. Nauseef W. 2002 The neutrophil NADPH oxidase ArchBiochemBiophys 397 342 344
7. Beckman JS. Koppenol WH. 1996 Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly AmJPhysiol 271 C1424 C1437
8. Behl C. 2005 Oxidative stress in Alzheimer's disease: implications for prevention and therapy SubcellBiochem 38 65 78
9. Behl C. Davis JB. Lesley R. Schubert D. 1994 Hydrogen peroxide mediates amyloid beta protein toxicity Cell 77 817 827
10. Bosetti F. Brizzi F. Barogi S. Mancuso M. Siciliano G. Tendi EA. Murri L. Rapoport SI. Solaini G. 2002 Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease NeurobiolAging 23 371 376
11. Bush AI. Atwood CS. Goldstein LE. Huang X. Rogers J. 2000 Could Abeta and AbetaPP be Antioxidants? JAlzheimersDis 2 83 84
12. Butterfield DA. Drake J. Pocernich C. Castegna A. 2001 Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide Trends MolMed 7 548 554
13. Cadenas E. Davies K. J. 2000 Mitochondrial free radical generation, oxidative stress, and aging Free. Radic. Biol. Med. 29 222 230
14. Cardoso SM. Santos S. Swerdlow RH. Oliveira CR. 2001 Functional mitochondria are required for amyloid beta-mediated neurotoxicity FASEB J 15 1439 1441
15. Cash AD. Perry G. Ogawa O. Raina AK. Zhu X. Smith MA. 2002 Is Alzheimer's disease a mitochondrial disorder? Neuroscientist 8 489 496
16. Casley CS. Canevari L. Land JM. Clark JB. Sharpe MA. 2002 Beta-amyloid inhibits integrated mitochondrial respiration and key enzyme activities JNeurochem 80 89 100
17. Chandrasekaran K. Giordano T. Brady DR. Stoll J. Hatanpää K. Martin LS. Rapoport SI. 1994 Impairment in gene expression ox oxidative metabolism in vulnerable brain regions in Alzheimer's disease NeurobiolAging 14 343 532
18. Chandrasekaran K. Hatanppa K. Brady DR. Rapoport SI. 1996 Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease ExpNeurol 142 80 88
19. Chandrasekaran K. Hatanpää K. Rapoport SI. Brady DR. 1997 Decreased expression of nuclear and mitochondrial DNA-encoded genes of oxidative phosphorylation in association neocortex in Alzheimer disease MolBrain Res 44 99 104
20. Cohen G. 1983 The pathobiology of Parkinson's disease: biochemical aspects of dopamine neuron senescence JNeural TransmSuppl 19 89 103
21. Colton CA. Snell J. Chernyshev O. Gilbert DL. 1994 Induction of superoxide anion and nitric oxide production in cultured microglia AnnNYAcadSci 738 54 63
22. Conte V. Uryu K. Fujimoto S. Yao Y. Rokach J. Longhi L. Trojanowski JQ. Lee VM. McIntosh TK. Pratico D. 2004 Vitamin E reduces amyloidosis and improves cognitive function in Tg2576 mice following repetitive concussive brain injury JNeurochem 90 758 764
23. Coskun PE. Beal MF. Wallace DC. 2004 Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication ProcNatl AcadSciUSA 101 10 726 10 731
24. Crouch PJ. Blake R. Duce JA. et al. 2005 Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42 JNeurosci 25 672 679
25. van Dongen M. van Rossum E. Kessels A. Sielhorst H. Knipschild P. 2003 Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial J. Clin. Epidemiol. 56 367 376
26. Feng Z. Chang Y. Cheng Y. Zhang BL. Qu ZW. Qin C. Zhang JT. 2004 Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer's disease JPineal Res 37 129 136
27. Fhan S. Cohen G. 1992 The oxidant stress hypothesis in Parkinson's disease: evidence supporting it AnnNeurol 32 804 881
28. Finkel T. Holbrook NJ. 2000 Oxidants, oxidative stress and the biology of ageing Nature 408 239 247
29. Fukumoto H. Cheung BS. Hyman BT. Irizarry MC. 2002 Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease ArchNeurol 59 1381 1319
30. Good PF. Werner P. Hsu A. Olanow CW. Perl DP. 1996 Evidence of neuronal oxidative damage in Alzheimer's disease AmJPathol 149 21 28
31. Grundman M. Petersen RC. Ferris SH. et al. 2004 Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials ArchNeurol 61 59 66
32. Haass C. Schlossmacher MG. Hung AY. Vigo-Pelfrey C. Mellon A. Ostaszewski BL. Lieberburg I. Koo EH. Schenk D. Teplow DB. 1992 Amyloid beta-peptide is produced by cultured cells during normal metabolism Nature 359 322 325
33. Hagen T. M. Liu J. Lykkesfeldt J. Wehr C. M. Ingersoll R. T. Vinarsky V. Bartholomew J. C. Ames B. N. 2002 Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress Proc. Natl. Acad. Sci. USA 99 1870 1875
34. Han D. Antunes F. Canali R. Rettori D. Cadenas E. 2003 Voltage-dependent anion channels control the release of the superoxide anion from mitochondria to cytosol JBiolChem 278 5557 5563
35. Hensley K. Carney J. M. Mattson M. P. Aksenova M. Harris M. Wu J. F. Floyd R. A. Butterfield D. A. 1994 A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease Proc. Natl. Acad. Sci. USA 91 3270 3274
36. Hirai K. Aliev G. Nunomura A. et al. 2001 Mitochondrial abnormalities in Alzheimer's disease JNeurosci 21 3017 3023
37. Howes MJ. Houghton PJ. 2003 Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function PharmacolBiochemBehav 75 513 527
38. Kanowski S. Hoerr R. 2003 Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial Pharmacopsychiatry 36 297 303
39. Keil U. Bonert A. Marques CA. et al. 2004 Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis JBiolChem 279 50 310 50 320
40. Keller JN. Pang Z. Geddes JW. Begley JG. Germeyer A. Waeg G. Mattson MP. 1997 Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid beta-peptide: role of the lipid peroxidation product 4-hydroxynonenal JNeurochem 69 273 284
41. Kelso GF. Porteous CM. Coulter CV. Hughes G. Porteous WK. Ledgerwood EC. Smith RA. Murphy MP. 2001 Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties JBiolChem 276 4588 4596
42. Kim HS. Lee JH. Lee JP. et al. 2002 Amyloid beta peptide induces cytochrome C release from isolated mitochondria Neuroreport 13 1989 1993
43. Kiprianova I. Schwab S. Fandrey J. Spranger M. 1997 Suppression of the oxidative burst in murine microglia by nitric oxide NeurosciLett 226 75 78
44. Kish SJ. Bergeron C. Rajput A. Dozic S. Mastrogiacomo F. Chang LJ. Wilson JM. DiStefano LM. Nobrega JN. 1992 Brain cytochrome oxidase in Alzheimer's disease JNeurochem 59 776 779
45. Le Bars PL. 2003 Response patterns of EGb 761 in Alzheimer's disease: influence of neuropsychological profiles Pharmacopsychiatry 36 S50 S55
46. Le WD. Colom LV. Xie WJ. Smith RG. Alexianu M. Appel SH. 1995 Cell death induced by beta-amyloid 1-40 in MES 23.5 hybrid clone: the role of nitric oxide and NMDA-gated channel activation leading to apoptosis Brain Res 686 49 60
47. Leutner S. Czech C. Schindowski K. Touchet N. Eckert A. Muller W. E. 2000 Reduced antioxidant enzyme activity in brains of mice transgenic for human presenilin-1 with single or multiple mutations Neurosci. Lett. 292 87 90
48. Li R. Lindholm K. Yang LB. et al. 2004 Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients ProcNatl AcadSciUSA 101 3632 3637
49. Lin MT. Simon DK. Ahn CH. Kim LM. Beal MF. 2002 High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain HumMolGenet 11 133 145
50. Liochev SI. Fridovich I. 1999 The relative importance of HO* and ONOO- in mediating the toxicity of O*- Free RadicBiolMed 26 777 778
51. Lim G. P. Chu T. Yang F. Beech W. Frautschy S. A. Cole G. M. 2001 The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse J. Neurosci. 21 8370 8377
52. Lovell MA. Ehmann WD. Butler SM. Markesbery WR. 1995 Elevated thiobarbituric acid-eactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease Neurology 45 1594 1601
53. Lu T. Pan Y. Kao SY. Li C. Kohane I. Chan J. Yankner BA. 2004 Gene regulation and DNA damage in the ageing human brain Nature 429 883 891
54. Lustbader JW. Cirilli M. Lin C. et al. 2004 ABAD directly links Abeta to mitochondrial toxicity in. Alzheimer's disease Science 304 448 452
55. Lyras L. Perry RH. Perry EK. Ince PG. Jenner P. Halliwell B. 1998 Oxidative damage to proteins, lipids, and antioxidant enzyme regions from patients with dementia with Lewy bodies JNeurochem 71 302 312
56. Manczak M. Park BS. Jung Y. Reddy PH. 2004 Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage Neuromolecular Med 5 147 162
57. Manczak M. Jung Y. Park BS. Partovi D. Reddy PH. 2005 Time-course of mitochondrial gene expressions in mice brains: implications for mitochondrial dysfunction, oxidative damage, cytochrome c release in aging JNeurochem 92 494 504
58. Mark RJ. Pang Z. Geddes JW. Uchida K. Mattson MP. 1997 Amyloid beta-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation JNeurosci 17 1046 1054
59. Markesbery WR. 1998 Oxidative stress hypothesis in Alzheimer's disease Free RadicBiolMed 23 134 147
60. Markesbery WR. Carney JM. 1999 Oxidative alterations in Alzheimer's disease Brain Pathol 9 133 146
61. Matsubara E. Bryant-Thomas T. Pacheco Quinto J. et al. 2003 Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer's disease JNeurochem 85 1101 1108
62. Mattson MP. 2004 Pathways towards and away from Alzheimer's disease Nature 430 631 639
63. Mattson M. P. 1995 Free radicals and disruption of neuronal ion homeostasis in AD: a role for amyloid beta-peptide? Neurobiol.
64. Mattson MP. Begley JG. Mark RJ. Furukawa K. 1997 Abeta25-35 induces rapid lysis of red blood cells: contrast with Abeta1-42 and examination of underlying mechanisms Brain Res 771 147 153
65. McLellan ME. Kajdasz ST. Hyman BT. Bacskai BJ. 2003 In vivo imaging of reactive oxygen species specifically associated with thioflavine S-positive amyloid plaques by multiphoton microscopy JNeurosci 23 2212 2217
66. Melov S. 2004 Modeling mitochondrial function in aging neurons Trends Neurosci 27 601 616
67. Melov S. Wolf N. Strozyk D. Doctrow SR. Bush AI. 2005 Mice transgenic for Alzheimer disease beta-amyloid develop lens cataracts that are rescued by antioxidant treatment Free RadicBiolMed 38 258 261
68. Montine K. S. Kim P. J. Olson S J. Markesbery W. R. Montine T. J 1997 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease J. Neuropathol. Exp. Neurol. 56 866 871
69. Morris MC. Beckett LA. Scherr PA. Hebert LE. Bennett DA. Field TS. Evans DA. 1998 Vitamin E and vitamin C supplement use and risk of incident Alzheimer disease Alzheimer DisAssocDisord 12 121 126
70. Morris MC. Evans DA. Bienias JL. Tangney CC. Bennett DA. Aggarwal N. Wilson RS. Scherr PA. 2002 Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study JAMA 287 3230 3237
71. Morris MC. Evans DA. Tangney CC. Bienias JL. Wilson RS. Aggarwal NT. Scherr PA. 2005 Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change AmJClinNutr 81 508 514
72. Muller FL. Liu Y. Van Remmen H. 2004 Complex III releases superoxide to both sides of the inner mitochondrial membrane JBiolChem 279 49064 49073
73. Nakashima H. Ishihara T. Yokota O. Terada S. Trojanowski JQ. Lee VM. Kuroda S. 2004 Effects of alpha-tocopherol on an animal model of tauopathies Free RadicBiolMed 37 176 186
74. Nunomura A. Perry G. Pappolla MA. Friedland RP. Hirai K. Chiba S. Smith MA. 2000 Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome JNeuropatholExpNeurol 59 1011 1017
75. Ono K. Hasegawa K. Naiki H. Yamada M. 2004 Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro JNeurosciRes 75 742 750
76. Pappolla MA. Chyan YJ. Omar RA. Hsiao K. Perry G. Smith MA. Bozner P. 1998 Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo AmJPathol 152 871 877
77. Park SY. Kim DS. 2002 Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer's disease JNatProd 65 1227 1231
78. Parker WD. Jr. Filley CM. Parks JK. 1990 Cytochrome oxidase deficiency in Alzheimer's disease Neurology 40 1302 1303
79. Parker WD. Jr. Parks J. Filley CMBK. Kleinschmidt-DeMasters BK. 1994 Electron transport chain defects in Alzheimer's disease brain Neurology 44 1090 1096
80. Pratico D. Uryu K. Leight S. Trojanoswki JQ. Lee VM. 2001 Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis JNeurosci 21 4183 4187
81. Qin L. Liu Y. Cooper C. Liu B. Wilson B. Hong JS. 2002 Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species JNeurochem 83 973 983
82. Radi R. Cassina A. Hodara R. Quijano C. Castro L. 2002 Peroxynitrite reactions and formation in mitochondria Free RadicBiolMed 33 1451 1464
83. Reddy PH. Beal MF. 2005 Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain ResRev 49 618 632
84. Reddy PH. McWeeney S. 2005 Mapping cellular transcriptosomes in autopsied Alzheimer's disease subjects and relevant mouse models NeurobiolAging in press )q32.
85. Reddy PH. McWeeney S. Park BS. et al. 2004 Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease HumMolGenet 13 1225 1240
86. Sayre LM. Zelasko DA. Harris PL. Perry G. Salomon RG. Smith MA. 1997 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease JNeurochem 68 2092 2097
87. Schriner SE. Linford NJ. Martin GM. et al. 2005 Extension of murine lifespan by overexpression of catalase targeted to mitochondria Science 308 909 911
88. Schulz V. 2003 Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trials and guidelines fail to consider Phytomedicine 10 74 79
89. Selkoe DJ. 2001 Alzheimer's disease: genes, proteins, and therapy PhysiolRev 81 741 766
90. Shoji M. Golde TE. Ghiso J. et al. 1992 Production of the Alzheimer amyloid beta protein by normal proteolytic processing Science 258 126 129
91. Simonian NA. Hyman BT. 1994 Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mtRNA in the hippocampal formation JNeuropatholExpNeurol 53 508 512
92. Smith MA. Perry G. Richey PL. Sayre LM. Anderson VE. Beal MF. Kowall N. 1996 Oxidative damage in Alzheimer's Nature 382 120 121
93. Smith MA. Richey PL. Sayre LM. Beckman JS. Perry G. 1997 Widespread peroxynitrite-mediated damage in Alzheimer's disease JNeurosci 17 2653 2657
94. Smith RA. Porteous CM. Coulter CV. Murphy MP. 1999 Selective targeting of an antioxidant to mitochondria EurJBiochem 263 709 716
95. Stackman R. W. Eckenstein F. Frei B. Kulhanek D. Nowlin J. Quinn J. F. 2003 Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment Exp. Neurol. 184 510 520
96. Starkov AA. Fiskum G. Chinopoulos C. Lorenzo BJ. Browne SE. Patel MS. Beal MF. 2004 Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species JNeurosci 24 7779 7788
97. Strazielle C. Sturchler-Pierrat C. Staufenbiel M. Lalonde R. 2003 Regional brain cytochrome oxidase activity in beta-amyloid precursor protein transgenic mice with the Swedish mutation Neuroscience 118 1151 1163
98. Sung S. Yao Y. Uryu K. Yang H. Lee VM. Trojanowski JQ. Pratico D. 2004 Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimer's disease FASEB J 18 323 325
99. Swerdlow RH. Khan SM. 2004 A 'mitochondrial cascade hypothesis' for sporadic Alzheimer's disease MedHypotheses 63 8 20
100. Swerdlow RH. Kish SJ. 2002 Mitochondria in Alzheimer's disease IntRevNeurobiol 53 341 385
101. Takuma K. Yao J. Huang J. Xu H. Chen X. Luddy J. Trillat AC. Stern DM. Arancio O. Yan SS. 2005 ABAD enhances Abeta-induced cell stress via mitochondrial dysfunction FASEB J 19 597 6088
102. Tamagno E. Bardini P. Obbili A. Vitali A. Borghi R. Zaccheo D. Pronzato M. A. Danni O. Smith M. A. Perry G. Tabaton M. 2002 Oxidative stress increases expression and activity of BACE in NT2 neurons Neurobiol. Dis. 10 279 288
103. Tanzi RE. Bertram L. 2005 Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective Cell 120 545 555
104. Trifunovic A. Wredenberg A. Falkenberg M. et al. 2004 Premature ageing in mice expressing defective mitochondrial DNA polymerase Nature 429 417 423
105. Turrens JF. 2003 Mitochondrial formation of reactive oxygen species JPhysiol 552 335 344
106. Vignais PV. 2002 The superoxide-generating NADPH oxidase: structural aspects and activation mechanism CellMolLife Sci 59 1428 1459
107. Wallace DC. 1999 Mitochondrial diseases in man and mouse Science 283 1482 1488
108. Yan SD. Yan SF. Chen X. et al. 1995 Non-enzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide NatMed 1 693 699
109. Yang F. Lim G. P. Begum A. N. Ubeda O. J. Simmons M. R. Ambegaokar S. S. Chen P. P. Kayed R. Glabe C. G. Frautschy S. A. Cole G. M. 2005 Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo J. Biol. Chem. 280 5892 5901
110. Yokoyama Y. Beckman JS. Beckman TK. Wheat JK. Cash TG. Freeman BA. Parks DA. 1990 Circulating xanthine oxidase: potential mediator of ischemic injury AmJPhysiol 258 G564 G570
111. Wong A. Luth H. J. Deuther-Conrad W. Dukic-Stefanovic S. Gasic-Milenkovic J. Arendt T. Munch G. 2001 Advanced glycation endproducts co-localize with inducible nitric oxide synthase in Alzheimer's disease Brain Res. 920 32 40
112. Zandi P. P. Anthony J. C. Khachaturian A. S. Stone S. V. Gustafson D. Tschanz J. T. Norton M. C. Welsh-Bohmer K. A. Breitner J. C. Cache County Study Group 2004 Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County Study Arch. Neurol. 61 82 88
113. Zhang ZJ. Qian YH. Hu HT. Yang J. Yang GD. 2003 The herbal medicine Dipsacus asper wall extract reduces the cognitive deficits and overexpression of beta-amyloid protein induced by aluminum exposure LifeSci 73 2443 2454
114. Zhu X. Lee HG. Casadesus G. Avila J. Drew K. Perry G. Smith MA. 2005 Oxidative imbalance in Alzheimer's disease MolNeurobiol 31 205 217